News
-
“CRDMO” the new business model for future of the (Bio)Pharma Industry
Today CDMOs face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm...
-
Angelini Pharma continues its commitment to HPAPI services
Facing the rising number of custom HPAPIs demand, Angelini Fine Chemicals decided to expand its HPAPI capacity at its Aprilia,Italy plant site
-
Flow Chemistry as novel chirotechnologic tool for asymmetric synthesis of APIs
The continuous-flow enantioselective processes have to be seen as a pivot point for sustainable development of the tomorrow’s pharmaceutical industry
-
Modern and future strategic trends of the pharma outsourcing market
Today Contract Development Manufacturing Organizations (CDMOs) face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm
-
Angelini Fine Chemicals increases the production of High Potent Active Pharmaceutical Ingredients
HPAPIs are becoming increasingly central to the world of the pharmaceutical industry.
